Annual Drug Patent Expirations for PEPAXTO
Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug.
This drug has seventy-six patent family members in twenty-seven countries.
The generic ingredient in PEPAXTO is melphalan flufenamide hydrochloride. Additional details are available on the melphalan flufenamide hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
